Work

Pegozafermin for the treatment of non-alcoholic steatohepatitis patients with F2/F3 fibrosis: a multi-center, randomized, double-blind, placebo-controlled Phase 2b trial (ENLIVEN)

Year: 2023

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(23)00456-7

Authors: Rohit Loomba, Arun Sanyal, Kris Kowdley, Deepak Bhatt, Naim Alkhouri, Juan P Frias, Pierre Bedossa, Stephen Harrison, Don Lazas, Robert Barish, Millie Gottwald, Shibao Feng, Germaine D. Agollah, Cynthia (Cindy) Hartsfield, Hank Mansbach, Maya Margalit, Manal Abdelmalek

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4384941408

FWCI: 0.2

Cites:

Cited by: 1

Related to: 10